1. Avis NE, Ory M, Matthews KA, et al. Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women’s Health Across the Nation (SWAN). Med Care2003;41(11):1262–76. Doi: 10.1097/01.MLR.0000093479.39115.AF. [PubMed] [CrossRef] [Google Scholar]
2. Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women’s Health Across the Nation. Menopause2009;16(5):860–9. Doi: 10.1097/gme.0b013e3181a3cdaf. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Blumel JE, Chedraui P, Baron G, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause2011;18(7):778–85. Doi: 10.1097/gme.0b013e318207851d. [PubMed] [CrossRef] [Google Scholar]
4. Williams RE, Levine KB, Kalilani L, et al. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life. Maturitas2009;62(2):153–9. Doi: 10.1016/j.maturitas.2008.12.006. [PubMed] [CrossRef] [Google Scholar]
5. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med2005;118Suppl 12B:14–24. Doi: 10.1016/j.amjmed.2005.09.031. [PubMed] [CrossRef] [Google Scholar]
6. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women’s health across the nation. Am J Public Health2006;96(7):1226–35. Doi: 10.2105/AJPH.2005.066936. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
7. Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause2014;21(9). Doi: 10.1097/GME.0000000000000196. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
8. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med2015;175(4):531–9. Doi: 10.1001/jamainternmed.2014.8063. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Freeman EW, Sammel MD, Lin H, et al. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol2011;117(5):1095–104. Doi: 10.1097/AOG.0b013e318214f0de. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
10. Williams RE, Kalilani L, DiBenedetti DB, et al. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas2007;58(4):348–58. Doi: 10.1016/j.maturitas.2007.09.006. [PubMed] [CrossRef] [Google Scholar]
11. Nicholson WK, Ellison SA, Grason H, et al. Patterns of ambulatory care use for gynecologic conditions: A national study. Am J Obstet Gynecol2001;184(4):523–30. Doi: 10.1067/mob.2001.111795. [PubMed] [CrossRef] [Google Scholar]
12. Thurston RC, Sowers MR, Sternfeld B, et al. Gains in body fat and vasomotor symptom reporting over the menopausal transition: The Study of Women’s Health Across the Nation. Am J Epidemiol2009;170(6):766–74. Doi: 10.1093/aje/kwp203. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, et al. Hot flashes and carotid intima media thickness among midlife women. Menopause2011;18(12):352–8. Doi: 10.1161/STROKEAHA.116.014674. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Crandall CJ, Tseng CH, Crawford SL, et al. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition. J Bone Miner Res2011;26(4):840–9. Doi: 10.1002/jbmr.259. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
15. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol1999;181(1):66–70. [PubMed] [Google Scholar]
16. Kronenberg F. Hot flashes: Epidemiology and physiology. Ann N Y Acad Sci1990;592:52–86. [PubMed] [Google Scholar]
17. Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab2005;90(11):6106–12. Doi: 10.1210/jc.2005-1374. [PubMed] [CrossRef] [Google Scholar]
18. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med2001;52(3):345–56. [PubMed] [Google Scholar]
19. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril2001;76:874–8. [PubMed] [Google Scholar]
20. Harlow SD, Karvonen-Gutierrez C, Elliott MR, et al. It is not just menopause: symptom clustering in the Study of Women’s Health Across the Nation. Womens Midlife Health2017;3(2):1–13. Doi: 10.1186/s40695-017-0021-y. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Cray LA, Woods NF, Herting JR, et al. Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women’s Health Study. Menopause2012;19(8):864–9. Doi: 10.1097/gme.0b013e31824790a6. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertil Steril2012;97(4):843–51. Doi: 10.1016/j.fertnstert.2012.01.128. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health1997;3(2):103–20. [PubMed] [Google Scholar]
24. Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric2008;11(1):32–43. Doi: 10.1080/13697130701744696. [PubMed] [CrossRef] [Google Scholar]
25. Hunter M, Gentry-Maharaj A, Ryan A, et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54–65. BJOG Int J Obstet Gynaecol2012;119(1):40–50. Doi: 10.1111/j.1471-0528.2011.03166.x. [PubMed] [CrossRef] [Google Scholar]
26. Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms?Menopause2008;15(5):841–7. Doi: 10.1097/gme.0b013e318168f09b. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
27. Sievert L, Makhlouf Obermeyer C, Price K. Determinants of hot flashes and night sweats. Ann Hum Biol2006;33(1):4–16. Doi: 10.1080/03014460500421338. [PubMed] [CrossRef] [Google Scholar]
28. Sievert LL. Subjective and objective measures of hot flashes. Am J Hum Biol2013;25(5):573–80. Doi: 10.1002/ajhb.22415. [PubMed] [CrossRef] [Google Scholar]
29. Whiteley J, Wagner J-S, Bushmakin A, et al. Impact of the severity of vasomotor symptoms on health status, resource use, and productivity: Menopause2013;20(5):1 Doi: 10.1097/GME.0b013e31827d38a5. [PubMed] [CrossRef] [Google Scholar]
30. Gold EB, Sternfeld B, Kelsey JL, et al. The relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol2000;152:463–73. [PubMed] [Google Scholar]
31. Politi MC, Schleinitz MD, Col NF Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med2008;23(9):1507–13. Doi: 10.1007/s11606-008-0655-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
32. North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause2017;24(7):728–53. Doi: 10.1097/GME.0000000000000921. [PubMed] [CrossRef] [Google Scholar]
33. Grady D, Ettinger B, Tosteson ANA, et al. Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol2003;102(6):1233–9. [PubMed] [Google Scholar]
34. Brunner RL, Aragaki A, Barnabei V, et al. Menopausal symptom experience before and after stopping estrogen therapy in the Women’s Health Initiative randomized, placebo-controlled trial: Menopause2010;17(5):946–54. Doi: 10.1097/gme.0b013e3181d76953. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
35. Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. J Am Med Assoc2005;294(2):183–93. Doi: 10.1001/jama.294.2.183. [PubMed] [CrossRef] [Google Scholar]
36. Espen Gjelsvik B, Straand J, Hunskaar S, et al. Use and discontinued use of menopausal hormone therapy by healthy women in Norway: the Hordaland Women’s Cohort study. Menopause2014;21(5):459–68. Doi: 10.1097/GME.0b013e3182a11f2d. [PubMed] [CrossRef] [Google Scholar]
37. Ness J, Aronow WS, Beck G. Menopausal symptoms after cessation of hormone replacement therapy. Maturitas2006;53(3):356–61. Doi: 10.1016/j.maturitas.2005.06.008. [PubMed] [CrossRef] [Google Scholar]
38. Gentry-Maharaj A, Karpinskyj C, Glazer C, et al. Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study. Menopause2015;22(4):384–90. Doi: 10.1097/GME.0000000000000330. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
39. American College of Obstetricians and Gynecologists Practice Bulletin No. 141: Management of menopausal symptoms. Obstet Gynecol2014;123(1):202–16. Doi: 10.1097/01.AOG.0000441353.20693.78. [PubMed] [CrossRef] [Google Scholar]
40. Soules MR, Bremner WJ. The menopause and climacteric: Endocrinologic basis and associated symptomatology. J Am Geriatr Soc1982;30(9):547–61. Doi: 10.1111/j.1532-5415.1982.tb05661.x. [PubMed] [CrossRef] [Google Scholar]
41. Nimrod A, Ryan KJ. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab1975;40(3):367–72. Doi: 10.1210/jcem-40-3-367. [PubMed] [CrossRef] [Google Scholar]
42. Herber-Gast G, Mishra GD, van der Schouw YT, et al. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause2013;20(9):953–9. Doi: 10.1097/GME.0b013e3182844a7c. [PubMed] [CrossRef] [Google Scholar]
43. Gold EB, Crawford SL, Shelton JF, et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Womenʼs Health Across the Nation (SWAN). Menopause2017;24(1):9–26. Doi: 10.1097/GME.0000000000000723. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
44. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the Study of Women’s Health Across the Nation. Am J Epidemiol2004;159(12):1189–99. Doi: 10.1093/aje/kwh168. [PubMed] [CrossRef] [Google Scholar]
45. Guthrie JR, Smith AM, Dennerstein L, et al. Physical activity and the menopause experience: a cross-sectional study. Maturitas1994;20:71–80. [PubMed] [Google Scholar]
46. Sternfeld B, Quesenberry CP, Husson G. Habitual physical activity and menopausal symptoms: a case-control study. J Womens Health1999;8(1):115–23. [PubMed] [Google Scholar]
47. Elavsky S, McAuley E. Physical activity, symptoms, esteem, and life satisfaction during menopause. Maturitas2005;52(3–4):374–85. Doi: 10.1016/j.maturitas.2004.07.014. [PubMed] [CrossRef] [Google Scholar]
48. Moilanen J, Aalto A-M, Hemminki E, et al. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas2010;67(4):368–74. Doi: 10.1016/j.maturitas.2010.08.007. [PubMed] [CrossRef] [Google Scholar]
49. Sternfeld B, Guthrie KA, Ensrud KE, et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause2014;21(4):330–8. Doi: 10.1097/GME.0b013e31829e4089. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
50. Schwingl P, Hulka B, Harlow S. Risk factors for menopausal hot flashes. Obstet Gynecol1994;84(1):29–34. [PubMed] [Google Scholar]
51. Freeman EW, Sammel MD, Grisso JA, et al. Hot flashes in the late reproductive years: Risk factors for African American and Caucasian women. J Womens Health Gend Based Med2001;10(1):67–76. Doi: 10.1089/152460901750067133. [PubMed] [CrossRef] [Google Scholar]
52. Lethaby A, Marjoribanks J, Kronenberg F, et al. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev2007;17(4):CD001395 Doi: 10.1002/14651858.CD001395.pub3. [PubMed] [CrossRef] [Google Scholar]
53. Lermer MA, Morra A, Moineddin R, et al. Somatic and affective anxiety symptoms and menopausal hot flashes. Menopause2011;18(2):129–32. Doi: 10.1097/gme.0b013e3181ec58f8. [PubMed] [CrossRef] [Google Scholar]
54. Freeman EW, Sammel MD, Lin H, et al. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause2005;12(3):258–66. [PubMed] [Google Scholar]
55. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause: Menopause2009;16(4):728–34. Doi: 10.1097/gme.0b013e3181967e16. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
56. Hunter MS, Chilcot J. Testing a cognitive model of menopausal hot flushes and night sweats. J Psychosom Res2013;74(4):307–12. Doi: 10.1016/j.jpsychores.2012.12.005. [PubMed] [CrossRef] [Google Scholar]
57. Thurston RC, Blumenthal JA, Babyak MA, et al. Emotional antecedents of hot flashes during daily life. Psychosom Med2005;67(1):137–46. Doi: 10.1097/01.psy.0000149255.04806.07. [PubMed] [CrossRef] [Google Scholar]
58. Hanisch LJ, Hantsoo L, Freeman EW, et al. Hot flashes and panic attacks: a comparison of symptomatology, neurobiology, treatment, and a role for cognition. Psychol Bull2008;134(2):247–69. Doi: 10.1037/0033-2909.134.2.247. [PubMed] [CrossRef] [Google Scholar]
59. Mishra GD, Dobson AJ. Using longitudinal profiles to characterize women’s symptoms through midlife: results from a large prospective study. Menopause2012;19(5):549–55. Doi: 10.1097/gme.0b013e3182358d7c. [PubMed] [CrossRef] [Google Scholar]
60. Tepper PG, Brooks MM, Randolph JF, et al. Characterizing the trajectories of vasomotor symptoms across the menopausal transition: Menopause2016;23(10):1067–74. Doi: 10.1097/GME.0000000000000676. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
61. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab2002;87(8):3760–7. Doi: 10.1210/jcem.87.8.8741. [PubMed] [CrossRef] [Google Scholar]
62. Lasley BL, Chen J, Stanczyk FZ, et al. Androstenediol complements estrogenic bioactivity during the menopausal transition: Menopause2012;19(6):650–7. Doi: 10.1097/gme.0b013e31823df577. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
63. Wilson LF, Pandeya N, Byles J, et al. Hot flushes and night sweats symptom profiles over a 17-year period in mid-aged women: The role of hysterectomy with ovarian conservation. Maturitas2016;91:1–7. Doi: 10.1016/j.maturitas.2016.05.011. [PubMed] [CrossRef] [Google Scholar]
64. Zeleke BM, Bell RJ, Billah B, et al. Vasomotor and sexual symptoms in older Australian women: a cross-sectional study. Fertil Steril2016;105(1):149–55. Doi: 10.1016/j.fertnstert.2015.09.017. [PubMed] [CrossRef] [Google Scholar]
65. Benshushan A, Rojansky N, Chaviv M, et al. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric2009;12(5):404–9. Doi: 10.1080/13697130902780846. [PubMed] [CrossRef] [Google Scholar]
66. Özdemir S, Çelik Ç, Görkemli H, et al. Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet2009;106(1):57–61. Doi: 10.1016/j.ijgo.2009.03.016. [PubMed] [CrossRef] [Google Scholar]
67. Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med2005;118(12):131–5. Doi: 10.1016/j.amjmed.2005.09.056. [PubMed] [CrossRef] [Google Scholar]
68. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol1999;180:S312–316. [PubMed] [Google Scholar]
69. Mom CH, Buijs C, Willemse PH, et al. Hot flushes in breast cancer patients. Crit Rev Oncol Hematol2006;57(1):63–77. Doi: 10.1016/j.critrevonc.2005.04.009. [PubMed] [CrossRef] [Google Scholar]
70. Davis SR, Panjari M, Robinson PJ, et al. Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis: Menopause2014;21(10):1075–81. Doi: 10.1097/GME.0000000000000219. [PubMed] [CrossRef] [Google Scholar]
71. Couzi RJ, Helzlsouer KJ, Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol1995;13(11):2737–44. Doi: 10.1200/JCO.1995.13.11.2737. [PubMed] [CrossRef] [Google Scholar]
72. Carpenter JS, Andrykowski MA, Cordova M, et al. Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer1998;82:1682–91. [PubMed] [Google Scholar]
73. Vincent AJ, Ranasinha S, Sayakhot P, et al. Sleep difficulty mediates effects of vasomotor symptoms on mood in younger breast cancer survivors. Climacteric2014;17(5):598–604. Doi: 10.3109/13697137.2014.900745. [PubMed] [CrossRef] [Google Scholar]
74. Olin JL, St PM. Aromatase inhibitors in breast cancer prevention. Ann Pharmacother2014;48(12):1605–10. Doi: 10.1177/1060028014548416. [PubMed] [CrossRef] [Google Scholar]
75. Maunsell E, Goss PE, Chlebowski RT, et al. Quality of life in MAP.3 (Mammary Prevention 3): A randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer. J Clin Oncol2014;32(14):1427–36. Doi: 10.1200/JCO.2013.51.2483. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
76. Biglia N, Cozzarella M, Cacciari F, et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas2003;45(1):29–38. [PubMed] [Google Scholar]
77. Cella D, Fallowfield LJ. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat2007;107(2):167–80. Doi: 10.1007/s10549-007-9548-1. [PubMed] [CrossRef] [Google Scholar]
78. Hickey M, Saunders CM, Stuckey BG. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet Oncol2005;6(1470–2045 (Print)):687–95. [PubMed] [Google Scholar]
79. Miller SR, Gallicchio LM, Lewis LM, et al. Association between race and hot flashes in midlife women. Maturitas2006;54(3):260–9. Doi: 10.1016/j.maturitas.2005.12.001. [PubMed] [CrossRef] [Google Scholar]
80. Walsh NE, Schoenfeld L, Ramamurthy S, et al. Normative model for cold pressor test. Am J Phys Med Rehabil1989;68(1):6–11. [PubMed] [Google Scholar]
81. Edwards RR, Fillingim RB. Ethnic differences in thermal pain responses. Psychosom Med1999;61(3):346–54. [PubMed] [Google Scholar]
82. Chapman WP, Jones CM. Variations in cutaneous and visceral pain sensitivity in normal subjects. J Clin Invest1944;23(1):81–91. Doi: 10.1172/JCI101475. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
83. Adler SR, Fosket JR, Kagawa-Singer M, et al. Conceptualizing menopause and midlife: Chinese American and Chinese women in the US. Maturitas2000;35(0378–5122):11–23. [PubMed] [Google Scholar]
84. Simpkins JW, Brown K, Bae S, et al. Role of ethnicity in the expression of features of hot flashes. Maturitas2009;63(4):341–6. Doi: 10.1016/j.maturitas.2009.06.002. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
85. Green R, Polotsky AJ, Wildman RP, et al. Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women’s Health Across the Nation. Climacteric2010;13(4):376–84. Doi: 10.3109/13697130903528272. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
86. Avis NE, Kaufert PA, Lock M, et al. The evolution of menopausal symptoms. Baillières Clin Endocrinol Metab1993;7(1):17–32. [PubMed] [Google Scholar]
87. Haines CJ, Chung TK, Leung DH. A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women. Maturitas1994;18(3):175–81. [PubMed] [Google Scholar]
88. Green R, Santoro N. Menopausal symptoms and ethnicity: The Study of Women’s Health across the Nation. Womens Health2009;5(2):127–33. Doi: 10.2217/17455057.5.2.127. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
89. Reed SD, Lampe JW, Qu C, et al. Premenopausal vasomotor symptoms in an ethnically diverse population: Menopause2014;21(2):153–8. Doi: 10.1097/GME.0b013e3182952228. [PubMed] [CrossRef] [Google Scholar]
90. Obermeyer CM. Menopause across cultures: a review of the evidence. Menopause2000;7(3):184–92. [PubMed] [Google Scholar]
91. Obermeyer CM, Reher D, Saliba M. Symptoms, menopause status, and country differences: a comparative analysis from DAMES. Menopause2007;14(4):788–97. Doi: 10.1097/gme.0b013e318046eb4a. [PubMed] [CrossRef] [Google Scholar]
92. Crawford SL. The roles of biologic and nonbiologic factors in cultural differences in vasomotor symptoms measured by surveys. Menopause2007;14(4):725–33. Doi: 10.1097/GME.0b013e31802efbb2. [PubMed] [CrossRef] [Google Scholar]
